Personalised selection of medication for newly diagnosed adult epilepsy: study protocol of a first-in-class, double-blind, randomised controlled trial.

Thom D, Chang RS, Lannin NA, Ademi Z, Ge Z, Reutens D, O'Brien T, D'Souza W, Perucca P, Reeder S, Nikpour A, Wong C, Kiley M, Saw JL, Nicolo JP, Seneviratne U, Carney P, Jones D, Somerville E, Stapleton C, Foster E, Vadlamudi L, Vaughan DN, Lee J, Farrar T, Howard M, Sparrow R, Chen Z, Kwan P

Open source

DOI: 10.1136/bmjopen-2024-086607
Published: 2025 Apr 5
Container: BMJ open
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2024-086607,
  title = {Personalised selection of medication for newly diagnosed adult epilepsy: study protocol of a first-in-class, double-blind, randomised controlled trial.},
  author = {Thom D and Chang RS and Lannin NA and Ademi Z and Ge Z and Reutens D and O'Brien T and D'Souza W and Perucca P and Reeder S and Nikpour A and Wong C and Kiley M and Saw JL and Nicolo JP and Seneviratne U and Carney P and Jones D and Somerville E and Stapleton C and Foster E and Vadlamudi L and Vaughan DN and Lee J and Farrar T and Howard M and Sparrow R and Chen Z and Kwan P},
  year = {2025},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2024-086607},
  url = {https://doi.org/10.1136/bmjopen-2024-086607}
}

RIS

TY  - JOUR
TI  - Personalised selection of medication for newly diagnosed adult epilepsy: study protocol of a first-in-class, double-blind, randomised controlled trial.
AU  - Thom D
AU  - Chang RS
AU  - Lannin NA
AU  - Ademi Z
AU  - Ge Z
AU  - Reutens D
AU  - O'Brien T
AU  - D'Souza W
AU  - Perucca P
AU  - Reeder S
AU  - Nikpour A
AU  - Wong C
AU  - Kiley M
AU  - Saw JL
AU  - Nicolo JP
AU  - Seneviratne U
AU  - Carney P
AU  - Jones D
AU  - Somerville E
AU  - Stapleton C
AU  - Foster E
AU  - Vadlamudi L
AU  - Vaughan DN
AU  - Lee J
AU  - Farrar T
AU  - Howard M
AU  - Sparrow R
AU  - Chen Z
AU  - Kwan P
PY  - 2025
JO  - BMJ open
DO  - 10.1136/bmjopen-2024-086607
UR  - https://doi.org/10.1136/bmjopen-2024-086607
ER  -

APA

D, T., RS, C., NA, L., Z, A., Z, G., D, R., T, O., W, D., P, P., S, R., A, N., C, W., M, K., JL, S., JP, N., U, S., P, C., D, J., E, S., C, S., E, F., L, V., DN, V., J, L., T, F., M, H., R, S., Z, C., & P, K. (2025). Personalised selection of medication for newly diagnosed adult epilepsy: study protocol of a first-in-class, double-blind, randomised controlled trial.. BMJ open. https://doi.org/10.1136/bmjopen-2024-086607

Source records

pubmed · retrieved 2026-09-27T10:46:45.357Z
europe-pmc · retrieved 2026-09-27T10:46:45.363Z
doaj · retrieved 2026-09-27T10:46:45.375Z